ICD-10: R50.2

Drug induced fever

Additional Information

Clinical Information

Overview of Drug-Induced Fever (ICD-10 Code R50.2)

Drug-induced fever, classified under ICD-10 code R50.2, is a clinical condition characterized by an elevated body temperature resulting from the administration of certain medications. This phenomenon can occur due to various mechanisms, including hypersensitivity reactions, direct drug effects, or as a result of drug interactions. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with drug-induced fever is crucial for accurate diagnosis and management.

Clinical Presentation

Patients with drug-induced fever typically present with a sudden onset of fever, which may vary in intensity and duration depending on the specific drug involved and the individual patient's response. The fever may be accompanied by other systemic symptoms, which can help differentiate it from other causes of fever.

Common Symptoms

  • Fever: The primary symptom, often exceeding 38°C (100.4°F).
  • Chills: Patients may experience chills or rigors accompanying the fever.
  • Malaise: A general feeling of discomfort or unease is common.
  • Rash: Some patients may develop a rash, indicating a hypersensitivity reaction.
  • Joint Pain: Arthralgia may occur in some cases, particularly with certain medications.

Signs

Upon examination, healthcare providers may observe the following signs in patients with drug-induced fever:

  • Elevated Temperature: A measured body temperature above the normal range.
  • Tachycardia: Increased heart rate may be noted, often as a physiological response to fever.
  • Skin Changes: Erythema or other dermatological signs may be present if a hypersensitivity reaction is involved.
  • Dehydration Signs: Due to fever, patients may exhibit signs of dehydration, such as dry mucous membranes or decreased skin turgor.

Patient Characteristics

Certain patient characteristics may predispose individuals to drug-induced fever:

  • Age: Older adults may be more susceptible due to polypharmacy and altered drug metabolism.
  • Gender: Some studies suggest that females may have a higher incidence of drug-induced fever, potentially due to hormonal differences affecting drug metabolism.
  • Comorbidities: Patients with underlying health conditions, such as autoimmune disorders or chronic infections, may be at increased risk.
  • Medication History: A history of previous drug reactions or allergies can indicate a higher likelihood of developing fever in response to certain medications.

Mechanisms of Drug-Induced Fever

Understanding the underlying mechanisms can aid in recognizing and managing drug-induced fever:

  • Hypersensitivity Reactions: Some drugs can trigger immune responses leading to fever.
  • Direct Pyrogenic Effects: Certain medications may directly stimulate the hypothalamus, resulting in increased body temperature.
  • Drug Interactions: Concurrent use of multiple medications can lead to increased toxicity and fever.

Conclusion

Drug-induced fever (ICD-10 code R50.2) is a significant clinical concern that requires careful evaluation of patient history, medication use, and clinical symptoms. Recognizing the signs and symptoms associated with this condition is essential for timely diagnosis and management. Clinicians should maintain a high index of suspicion, especially in patients presenting with fever shortly after starting new medications or changing dosages. Proper identification and management of the offending agent can lead to resolution of the fever and improvement in patient outcomes.

Description

ICD-10 code R50.2 refers to "Drug induced fever," a specific diagnosis used to classify fevers that arise as a direct result of medication use. Understanding this condition involves examining its clinical description, potential causes, diagnostic criteria, and management strategies.

Clinical Description

Drug induced fever is characterized by an elevation in body temperature that occurs as a side effect of certain medications. This type of fever can manifest in various ways, including:

  • Onset: The fever typically develops after the initiation of a new medication or an increase in dosage of an existing one. The timing can vary, with some patients experiencing fever within hours to days after exposure.
  • Symptoms: Patients may present with a range of symptoms, including chills, sweating, malaise, and other systemic signs of infection, although no infectious agent is present.
  • Temperature: The fever can be mild to moderate, often exceeding 38°C (100.4°F), and may be persistent or intermittent.

Common Causes

Several classes of drugs are known to potentially induce fever, including:

  • Antibiotics: Certain antibiotics, such as penicillins and cephalosporins, can trigger fever as an adverse reaction.
  • Anticonvulsants: Medications like phenytoin and carbamazepine have been associated with drug-induced fever.
  • Non-steroidal anti-inflammatory drugs (NSAIDs): Some NSAIDs can lead to fever in sensitive individuals.
  • Chemotherapeutic agents: Drugs used in cancer treatment may also cause febrile reactions.

Diagnostic Criteria

Diagnosing drug induced fever involves a thorough clinical evaluation, including:

  1. Patient History: A detailed medication history is crucial, including the timing of fever onset relative to drug administration.
  2. Physical Examination: Assessing for other signs of drug reactions, such as rashes or organ dysfunction.
  3. Exclusion of Other Causes: It is essential to rule out infections, malignancies, and other non-drug-related causes of fever through laboratory tests and imaging studies.

Management Strategies

The management of drug induced fever primarily focuses on:

  • Identifying the Causative Agent: Discontinuing the suspected medication is the first step in management. This often leads to a resolution of fever within a few days.
  • Supportive Care: Patients may require symptomatic treatment, including antipyretics to manage fever and discomfort.
  • Monitoring: Close observation is necessary to ensure that fever resolves and to monitor for any potential complications related to the underlying condition for which the medication was prescribed.

Conclusion

ICD-10 code R50.2 for drug induced fever highlights the importance of recognizing medication-related adverse effects in clinical practice. Proper identification and management of this condition can prevent unnecessary investigations and treatments, ensuring that patients receive appropriate care. If a patient presents with unexplained fever, a thorough medication review is essential to determine if drug-induced fever is a potential cause.

Approximate Synonyms

ICD-10 code R50.2 specifically refers to "Drug-induced fever," a condition characterized by an elevated body temperature resulting from the administration of certain medications. Understanding alternative names and related terms for this diagnosis can enhance clarity in medical documentation and communication. Below are some alternative names and related terms associated with R50.2.

Alternative Names for Drug-Induced Fever

  1. Medication Fever: This term is often used interchangeably with drug-induced fever and emphasizes the role of medications in causing elevated body temperature.

  2. Pharmacologic Fever: This term highlights the fever's association with pharmacological agents, indicating that the fever is a side effect of drug therapy.

  3. Drug Fever: A more general term that encompasses any fever caused by drugs, not limited to specific medications.

  4. Adverse Drug Reaction Fever: This term refers to fever as a result of an adverse reaction to a drug, which can include a variety of symptoms beyond fever itself.

  5. Therapeutic Fever: Sometimes used to describe fever that occurs as a result of therapeutic interventions, including drug treatments.

  1. Fever of Unknown Origin (FUO): While not synonymous, this term may be relevant in cases where drug-induced fever is suspected but not immediately identified, necessitating further investigation.

  2. Hyperthermia: Although hyperthermia refers to an elevated body temperature due to external factors or excessive heat production, it can sometimes be confused with drug-induced fever.

  3. Drug Hypersensitivity: This broader term encompasses various reactions to drugs, including fever, and may be relevant in discussions about drug-induced fever.

  4. Febrile Reaction: A general term that can refer to any feverish response, including those induced by drugs.

  5. Antibiotic Fever: Specifically refers to fever that may occur as a reaction to antibiotic therapy, which can be a subset of drug-induced fever.

Conclusion

Understanding the alternative names and related terms for ICD-10 code R50.2 is essential for healthcare professionals in accurately diagnosing and documenting cases of drug-induced fever. These terms can facilitate better communication among medical staff and improve patient care by ensuring that all potential causes of fever are considered and addressed.

Diagnostic Criteria

The ICD-10 code R50.2 refers specifically to "Drug induced fever," which is categorized under the broader classification of fever. Diagnosing drug-induced fever involves several criteria and considerations to ensure accurate identification and management. Below, we explore the diagnostic criteria and relevant factors associated with this condition.

Diagnostic Criteria for Drug Induced Fever (ICD-10 Code R50.2)

1. Clinical Presentation

  • Fever Onset: The patient typically presents with an elevated body temperature, often exceeding 38°C (100.4°F). The fever may develop shortly after the initiation of a new medication or an increase in dosage of an existing medication.
  • Symptoms: Accompanying symptoms may include chills, sweating, malaise, and other systemic signs that can vary depending on the individual and the specific drug involved.

2. Temporal Relationship

  • Timing of Drug Administration: A critical aspect of diagnosis is establishing a temporal relationship between the administration of a drug and the onset of fever. This includes reviewing the patient's medication history to identify any new drugs or changes in dosage that coincide with the fever's onset.
  • Duration of Fever: The fever should persist for the duration of the drug's action or until the drug is discontinued, which helps to support the diagnosis of drug-induced fever.

3. Exclusion of Other Causes

  • Differential Diagnosis: It is essential to rule out other potential causes of fever, such as infections, malignancies, or autoimmune diseases. This may involve laboratory tests, imaging studies, and clinical evaluations to confirm that the fever is not due to an underlying condition unrelated to drug use.
  • Laboratory Tests: Blood tests, cultures, and other diagnostic procedures may be performed to exclude infections or other inflammatory processes.

4. Response to Drug Withdrawal

  • Fever Resolution: A key indicator of drug-induced fever is the resolution of fever upon discontinuation of the suspected medication. Monitoring the patient after stopping the drug can provide further evidence supporting the diagnosis.

5. Patient History and Medication Review

  • Comprehensive Medication History: A thorough review of the patient's medication history, including over-the-counter drugs, herbal supplements, and recent changes in medication, is crucial. Certain classes of drugs, such as antibiotics, anticonvulsants, and non-steroidal anti-inflammatory drugs (NSAIDs), are more commonly associated with drug-induced fever.
  • Allergic Reactions: Consideration of any known drug allergies or previous adverse reactions to medications can also aid in the diagnosis.

Conclusion

Diagnosing drug-induced fever (ICD-10 code R50.2) requires a careful assessment of clinical symptoms, a thorough medication history, and the exclusion of other potential causes of fever. The temporal relationship between drug administration and fever onset, along with the patient's response to drug withdrawal, plays a pivotal role in confirming the diagnosis. Clinicians must remain vigilant in identifying this condition, as it can significantly impact patient management and treatment strategies.

Treatment Guidelines

Understanding Drug-Induced Fever (ICD-10 Code R50.2)

Drug-induced fever, classified under ICD-10 code R50.2, refers to an elevated body temperature resulting from the administration of medications. This condition can arise from various drug classes, including antibiotics, anticonvulsants, and non-steroidal anti-inflammatory drugs (NSAIDs). Recognizing and managing drug-induced fever is crucial, as it can lead to unnecessary investigations and treatments if not properly identified.

Standard Treatment Approaches

1. Identifying the Causative Agent

The first step in managing drug-induced fever is to identify the offending medication. This typically involves:

  • Patient History: A thorough review of the patient's medication history, including recent changes in prescriptions or over-the-counter drugs.
  • Timing: Assessing the onset of fever in relation to the initiation of drug therapy. Fever often develops within days to weeks after starting a new medication.

2. Discontinuation of the Offending Drug

Once the causative agent is identified, the standard treatment approach is to discontinue the medication. This is often sufficient to resolve the fever. In some cases, the fever may persist for a few days after stopping the drug, but it typically resolves as the drug is eliminated from the body[1].

3. Supportive Care

Supportive care is essential in managing symptoms associated with drug-induced fever. This may include:

  • Hydration: Ensuring adequate fluid intake to prevent dehydration, especially if the fever is high.
  • Antipyretics: Administering medications such as acetaminophen or ibuprofen to reduce fever and improve comfort. These should be used judiciously, particularly in patients with underlying conditions that may be exacerbated by these medications[2].

4. Monitoring and Follow-Up

Patients should be monitored for the resolution of fever and any potential complications. Follow-up appointments may be necessary to ensure that the fever has resolved and to assess for any delayed reactions to the medication.

5. Alternative Medications

If the drug causing the fever is essential for the patient's treatment, healthcare providers may consider alternative medications that do not have a similar risk of inducing fever. This requires careful evaluation of the patient's condition and potential alternatives[3].

Conclusion

Drug-induced fever (ICD-10 code R50.2) is a manageable condition that primarily involves identifying and discontinuing the offending medication. Supportive care, including hydration and antipyretics, plays a vital role in patient comfort. Continuous monitoring and follow-up are essential to ensure the resolution of symptoms and to explore alternative treatment options if necessary. By following these standard treatment approaches, healthcare providers can effectively manage drug-induced fever and minimize its impact on patient care.


References

  1. A Validation Study of Danish ICD-10 Diagnosis Codes - PMC.
  2. Fever of Unknown Origin: A Validation Study of Danish ICD ... - PMC.
  3. FY2022 April1 update ICD-10-CM Guidelines FY2022 April1 update ICD-10-CM Guidelines.

Related Information

Clinical Information

Description

Approximate Synonyms

  • Medication Fever
  • Pharmacologic Fever
  • Drug Fever
  • Adverse Drug Reaction Fever
  • Therapeutic Fever
  • Fever of Unknown Origin (FUO)
  • Hyperthermia
  • Drug Hypersensitivity
  • Febrile Reaction
  • Antibiotic Fever

Diagnostic Criteria

  • Fever Onset: Body temperature exceeds 38°C
  • Timing of Drug Administration: Fever after drug initiation or increase
  • Duration of Fever: Persists during drug action or until stopped
  • Exclusion of Other Causes: Rule out infections, malignancies, and autoimmune diseases
  • Laboratory Tests: Exclude infections or inflammatory processes
  • Response to Drug Withdrawal: Fever resolves upon stopping the suspected medication
  • Comprehensive Medication History: Review all medications, including OTC and herbal supplements

Treatment Guidelines

  • Identify causative medication
  • Discontinue offending drug
  • Provide hydration
  • Administer antipyretics cautiously
  • Monitor for resolution of fever
  • Consider alternative medications if necessary

Coding Guidelines

Use Additional Code

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Excludes 1

  • postvaccination (postimmunization) fever (R50.83)

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.